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CD90þ Human Dermal Stromal Cells Are Potent
Inducers of FoxP3þ Regulatory T Cells
Karin Pfisterer1,3, Karoline M. Lipnik2, Erhard Hofer2 and Adelheid Elbe-Bu¨rger1
The skin has to effectively combat external attacks, while maintaining skin immune homeostasis under steady-
state conditions. To fulfill these challenging tasks, the dermis harbors a variety of heterogeneous cell types that
are able to suppress T-cell proliferation similar to bone marrow mesenchymal stromal cells. Here we show that
plastic-adherent, human dermal cells induce FoxP3 expression in TCR-complex–stimulated CD25CD4þ
CD45RAþ T cells in the absence of CD28 co-ligation in a cell-contact–dependent manner. These FoxP3þ T cells
reveal an effective suppressive capacity in vitro. Moreover, we found that the vast majority of CD90þ dermal cells
are perivascularly located and generate a significantly higher percentage of regulatory T cells compared with cells
expressing markers such as CD271 in vitro. Importantly, we further demonstrate that plastic-adherent dermal cells
are also able to differentiate toward the endothelial lineage. Our data show that human skin harbors specific cell
types with immunosuppressive potential, which are located in close vicinity to their likely operational area and
provide evidence for a CD28-independent regulatory mechanism. Further, the differentiation potential into
endothelial cells suggests the existence of a tissue-resident cell pool for vessel regeneration. These findings
might have important implications for the clinical use of allogeneic dermal cells to rebuild an imbalanced human
skin immune homeostasis.
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INTRODUCTION
Healthy human skin as a main primary barrier prevents
microbial invasion. Resident T cells (10–20 billion) respond
to environmental antigens and are responsible for cutaneous
immunosurveillance (Kupper and Fuhlbrigge, 2004; Nestle
et al., 2009). Dermal T cells predominantly expressing CD4
(Clark et al., 2006) are located around postcapillary venules
and close to the epidermal–dermal junction (Nestle et al.,
2009). One of the most prominent cellular guards of
peripheral tolerance are regulatory T cells (Tregs) controlling
the activation and expansion of aberrant, over- or self-reactive
lymphocytes (Sakaguchi et al., 2008) and thus preventing
overwhelming pathophysiological immune responses (Dudda
et al., 2008). Particularly the skin harbors a high percentage of
Tregs (Dudda et al., 2008), which are increased in cancerous
skin malignancies (Kaporis et al., 2007; Clark et al., 2008) and
possess reduced suppressive capacity in lesional skin of
psoriatic patients (Sugiyama et al., 2005), suggesting a major
role for Tregs in maintaining skin immune homeostasis (Dudda
et al., 2008). Tregs express CD4, CD25, and the transcription
factor forkhead box P3 (FoxP3) (Hori et al., 2003) and are
mostly negative for CD127 (Liu et al., 2006; Allan et al., 2007;
Kmieciak et al., 2009). Naturally occurring (n)Tregs are
generated in the thymus through presentation of self-peptides
by thymus-resident stromal cells (Sakaguchi et al., 2008). Tregs
can be generated from naive CD4þCD45RAþ T cells in vitro
(Chen et al., 2003) and in vivo (Akbar et al., 2003). Thymic
dendritic cells (Watanabe et al., 2005) and/or stromal cells
(Sakaguchi et al., 2008) regulate the positive selection of self-
reactive thymocytes and generate FoxP3þ Tregs via provision
of costimulatory molecules (CD80, CD86) through ligation of
CD28 (Sakaguchi et al., 2008).
Mesenchymal stromal cells (MSCs) are plastic-adherent,
self-renewing, multipotent cells that express a set of stem cell
markers but lack hematopoietic markers (Caplan, 1991;
Dominici et al., 2006). They are localized in virtually every
prenatal and adult tissue, including human skin (Fernandes
et al., 2004; Toma et al., 2005; da Silva et al., 2006;
Chamberlain et al., 2007; Hunt et al., 2008; Vaculik et al.,
2012). MSCs suppress a great variety of lymphocytes and
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differentiate and expand Tregs (English, 2013), thus displaying
features that favor their use for transplantation (Nauta and
Fibbe 2007; Engela et al., 2012; Roemeling-van et al., 2012).
Immunomodulation by MSCs can be facilitated by cell–cell
contact and the release of soluble factors such as transforming
growth factor-b (TGF-b), IL-10, and HLA-G5 (English, 2013).
Importantly, MSCs do not express HLA class II or costimu-
latory molecules, rendering these cells hypoimmunogenic
(Porada et al., 2006). Dermal fibroblasts obviously share this
functional feature (Haniffa et al., 2007) as they are able to
suppress the proliferation of peripheral blood mononuclear
cells and allogeneic T cells in vitro via similar mechanisms.
We reported recently that the human dermis harbors MSC
subsets that differ in their mesenchymal differentiation poten-
tial (Vaculik et al., 2012). In this study, we aimed to determine
whether dermal subsets also display distinct immuno-
suppressive features and, if so, whether the induction of
Tregs may be involved in this process. Furthermore, we
explored their differentiation potential toward the endothelial
lineage.
RESULTS
CD73þCD90þCD105þ dermal cells suppress CD3/CD28-
induced T-cell proliferation
We have previously described that mesenchymal markers
such as CD73, CD90, CD105, CD271, and SSEA-4 are
expressed on different dermal cell subsets when cryostat
sections and single-cell suspensions are analyzed by immuno-
histochemistry and flow cytometry, respectively. Functional
experiments demonstrated that CD271þ and SSEA-4þ adher-
ent dermal cells had superior capacity for mesenchymal
differentiation compared with the respective negative fractions
(Vaculik et al., 2012). In this study, a further characterization
of in vitro cultured, adherent dermal cells by immunofluo-
rescence and confocal laser scanning microscopy revealed
that the great majority expressed CD73, CD90, and CD105
and displayed a fibroblastoid morphology (Figure 1a). Few
cells expressed alpha-smooth muscle actin, an actin micro-
filament of smooth musculature (Peled et al., 1991), or
CD271, a marker used to define a MSC subset with high
clonogenic potential (Quirici et al., 2002). These data show
that the human dermis harbors cells that may control the
proliferation of activated T cells in vivo. Carboxyfluoresceine
succinimidyl ester-based in vitro coculture assays
were performed to verify the inhibitory potential of plastic-
adherent human dermal cells on T-cell prolifera-
tion. Indeed, they decreased CD3/CD28-induced T-cell
proliferation in a cell density–dependent manner, which was
essentially equivalent with plastic-adherent human bone
marrow (BM) cells (positive control) (Haniffa et al., 2007),
whereas human embryonic kidney (HEK) cells (negative control)
did not affect T-cell proliferation (data not shown). These
results were confirmed using a conventional [3H]-thymidine
(TdR) incorporation assay. High dermal cell numbers (dermal
cell:T-cell ratio¼1:10, 1:5) exerted a suppressive effect on
T-cell proliferation, whereas low numbers (dermal cell:T-cell
ratio¼ 1:50) enhanced T-cell proliferation compared with
T cells alone or HEK cells (Figure 1b, white bars).
Dermal cells induce FoxP3 expression in
CD25CD4þCD45RAþ T cells irrespective of CD28
costimulation
MSCs from bone marrow (BM-MSCs) have been reported to
recruit, regulate, and stimulate Tregs (Prevosto et al., 2007;
Di Ianni et al., 2008) and induce the differentiation of
CD4þCD45RAþ T cells toward a regulatory phenotype
(Maccario et al., 2005; English et al., 2009). To determine
whether a similar mechanism may be operative for skin cells,
we analyzed T cells for FoxP3 expression before and after
coculture with plastic-adherent dermal cells. Indeed, we found
that dermal cells, but not HEK cells, significantly increased
FoxP3 expression in CD25CD4þCD45RAþ T cells upon
stimulation with aCD3/28-coated beads (Figure 1c). To exclude
the induction of a transient, unstable FoxP3 expression as
reported (Liang et al., 2005; Kmieciak et al., 2009), we
introduced a more physiological, CD28-independent cocul-
ture system, which is not based on antigen-induced upregu-
lation of CD80 or CD86, thus possibly mimicking the situation
in healthy skin. Coculture of highly purified T cells with
plastic-adherent dermal or BM cells in the absence of CD28-
induced signaling showed that low numbers of both dermal
and BM cells delivered a second stimulus in addition to the
TCR-complex–induced activation via aCD3 mAbs, thereby
inducing the proliferation of initially CD25CD4þCD45RAþ
T cells (Figure 1d, histogram overlays: with adherent cells,
black line; without adherent cells, gray filled). Intriguingly, we
found that under these conditions FoxP3þ T cells were
generated in the presence but not in the absence of dermal
and BM cells (Figure 1d). We next investigated whether CD80
and CD86 are upregulated in our cocultures and found that
dermal cells failed to express these markers before and after
coculture with CD25CD4þCD45RAþ T cells (Figure 1e).
To mimic inactivated resting antigen-presenting cells (APCs),
we used aCD3-coupled spherical beads and confirmed our
results showing an increase in FoxP3 expression in initially
CD25CD4þCD45RAþ T cells upon coculture with selected
densities of dermal as well as BM cells compared with
stimulated T cells alone. These data are illustrated in combi-
nation with proliferation to demonstrate the indirect correla-
tion between FoxP3 positivity (Figure 1b, black bars) and the
proliferative response of T cells (Figure 1b, white bars).
Increasing dermal cell numbers augmented the percentage
of FoxP3þ T cells and elevated the suppression of T-cell
proliferation. Of note, proliferation data most likely represent
combined values of effector and responder T-cell proliferation.
As FoxP3 is induced in CD25CD4þCD45RAþ T cells upon
coculture with dermal cells without CD80/CD86 ligation of
CD28, we propose a regulatory mechanism independent of
activated APCs.
Dermal cell–induced FoxP3þCD4þ T cells possess suppressive
capacity
To further characterize dermal cell–induced FoxP3þCD4þ T
cells, we included CD127 and CD25 in our analysis. Strik-
ingly, CD127 was downregulated on these T cells (Figure 2a),
which is in line with a report showing that low CD127
expression inversely correlates with FoxP3 expression in
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Figure 1. Plastic-adherent dermal cells induce forkhead box P3 (FoxP3) expression without CD28 ligation. (a) Cultured dermal cells were stained with the
indicated mAbs in chamber slides and analyzed with a confocal laser scanning microscope. Bars¼ 20mm. (b) Suppressive and FoxP3-inducing potential of plastic-
adherent dermal cells. Isolated dermal cells, bone marrow (BM) cells (positive control), and human embryonic kidney (HEK) cells (negative control) were irradiated
and seeded in different cell numbers (dermal cells at 1 103, 5103, and 1 104 cells per well and BM-mesenchymal stromal cells (MSCs) and HEK cells at
5 103 cells per well) and left to adhere o/n. Next day, isolated pan T cells (for the assessment of proliferation) or CFSE-labeled CD25CD4þCD45RAþ T cells
(for FoxP3-induction) were added to obtain cell ratios ranging from 1:50 to 1:5 (adherent cells:T cells) and stimulated with aCD3/CD28-coated and CD3-coated
beads, respectively. For the analysis of the suppressive capacity, T cells were labeled with [3H]-TdR for the last 18hours of culture and harvested on day 4. FoxP3
expression was evaluated in CFSE-negative cells by means of flow cytometry. Shown are normalized mean values (% of max±SD) of one representative
experiment out of two. (c) aCD3/CD28-bead–stimulated CFSE-stained CD25CD4þCD45RAþ T cells were cocultured with dermal or HEK cells (ratio 1:50) and
analyzed by flow cytometry. FoxP3 expression was determined and specificity was confirmed with isotype-matched controls (mean expression of triplicates). The
Mann–Whitney U-test, *Po0.05. (d) CFSE-stained CD25CD4þCD45RAþ T cells were stimulated with plate-bound aCD3 mAbs (1mgml–1) with (black line) and
without (gray filled) dermal or BM cells (ratio¼ 1:50) for 5 days and analyzed (representative experiment out of 3). (e) Flow cytometric analysis of CD80 and CD86
expression on dermal cells prior to and after coculture with T cells. CFSE, carboxyfluoresceine succinimidyl ester; NS, not significant.
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natural Tregs (Liu et al., 2006). CD25 expression was strongly
increased and significantly higher in dermal cell–induced
FoxP3þCD4þ T cells compared with BM cells (Figure 2b).
Simultaneous detection of CD25, CD127, and FoxP3 in
aCD3-stimulated carboxyfluoresceine succinidyl ester-labeled
CD25CD4þCD45RAþ T cells upon coculture with dermal
cells and BM cells but not with HEK cells revealed increased
CD25 expression paralleled with a downregulation of CD127
(Supplementary Figure S1a and b online). Of note, aCD3-
stimulated CD25CD4þCD45RAþ T cells predominantly
proliferated in the presence of plastic-adherent dermal and
BM cells and marginally with HEK cells, implying that induc-
tion of proliferation is a unique feature of fibroblastoid cells.
When dermal cell–induced FoxP3þCD4þ T cells were
tested for their functional capacity, we found that they were
able to significantly suppress the proliferation of CD25-
depleted, aCD3/CD28-activated T cells, confirming their Treg
nature, whereas T cells that were cultured in the presence of
HEK cells failed to suppress proliferation (Figure 2c). These
findings suggest that dermal cells in vivo may have the
potential to generate induced Tregs with suppressive potential
under homeostatic conditions.
TGF-b is a prominent candidate for induction of FoxP3
(Chen et al., 2003; Coombes et al., 2007; Yamazaki et al.,
2007) and is secreted by BM-MSCs (Jones and McTaggart
2008). To investigate whether this factor may also have a role
in the dermis, immunohistochemistry of healthy human adult
skin was performed. With the exception of basal keratino-
cytes, the epidermis expressed high levels of TGF-b1, whereas
this cytokine was virtually absent in the dermis (Figure 2d),
confirming our previously reported results (Schuster et al.,
2009). As we used isolated, plastic-adherent dermal cells for
our functional experiments, we additionally analyzed cell
culture supernatants of dermal cells cultured for 5 days and,
for comparison, BM cells and HEK cells for the presence/
absence of TGF-b1. We found that supernatants of dermal
cells and BM cells but not HEK cells contained detectable
levels of secreted TGF-b1 (3–5ngml–1) (Figure 2e). In contrast,
no TGF-b1 was present in crude cell lysates of cultured,
plastic-adherent dermal cells and HEK cells when compared
with freshly isolated epidermal cells (positive control) using
western blot analysis (Figure 2f). Next, we comparatively
assessed isolated BM cells and dermal cells, cultured for
several days in chamber slides, for the expression of the
latency-associated peptide (LAP)––a protein that forms a
complex with the TGF-b precursor (Schuster et al., 2009).
We found a slightly higher LAP expression (mean arbitrary
unit¼6,918) in dermal cells compared with BM cells (mean
arbitrary unit¼ 4,587) (Figure 2g). To address whether TGF-b
has a role in the induction of FoxP3 via dermal cells, we
added selected concentrations of an aTGF-b-blocking mAb in
our coculture system. We found a concentration-dependent
reduction of FoxP3-expressing T cells cultured with dermal
cells or BM cells (Supplementary Figure S2a online). Neither
the addition of an aHLA-G5-blocking mAb nor the addition of
indomethacin, which blocks indoleamine 2,3-dioxygenase or
prostaglandin E2, reduced the FoxP3 expression (Supple-
mentary Figure S2b and c online). However, the dermal
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Figure 2. Dermal cells induce functional forkhead box P3þ (FoxP3þ ) Tregs.
(a) FoxP3-expressing T cells were analyzed for CD127 coexpression. (b) T cells
were stimulated alone (T cells) or in coculture with dermal cells (Dermis)
and bone marrow (BM) cells (Bone marrow) and analyzed for CD25
expression. t-Test, *Po0.05, ***Po0.001. Gates were set according to the
isotype controls. (c) T cells from dermal and human embryonic kidney (HEK)
cell cocultures were recovered, irradiated, and used as effector cells (Teff) in
suppression assays with third-party CD25 T cells (Tresp). t-Test, **Po0.01,
***Po0.001. (d) Transforming growth factor-b1 (TGF-b1) expression in healthy
breast skin was detected via immunohistochemistry (inset¼ isotype control).
Bar¼50mm. (e) TGF-b1 amounts in supernatants of indicated plastic-adherent
cells were measured via the Luminex system. Shown are mean values of
duplicates±SD. (f) TGF-b expression of freshly isolated epidermal and
cultured, plastic-adherent dermal and HEK cells was determined by western
blot analysis. (g) Latency-associated protein (LAP) expression of BM (mean
arbitrary units (AU): 4,587) and dermal cells (mean AU: 6,918) was detected
via aLAP and AF488 secondary Abs (insets¼ isotype control). Bars¼ 20mm.
CFSE, carboxyfluoresceine succinimidyl ester; NS, not significant.
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cell–induced inhibition of T-cell proliferation could be res-
cued via addition of indomethacin, whereas the solvent
showed no effect (Supplementary Figure S2d online). As
cell-free supernatants from dermal or BM cells were not
sufficient to induce FoxP3 in aCD3-stimulated CD25CD4þ
CD45RAþ T cells (data not shown), additional factors beneath
TGF-b seem to be mandatory to induce FoxP3þ Tregs. To
address this, we analyzed cell culture supernatants from
plastic-adherent dermal cells, BM cells, and HEK cells for
secretion of several cytokines. We found that plastic-adherent
cells, irrespective of the tissue source, secreted either no or
negligible amounts of cytokines that have been tested in our
functional assays as indicated below (data not shown).
Next, we analyzed the cytokine profile upon coculture of
three different plastic-adherent cell types (dermal cells, BM
cells (positive control), HEK cells (negative control)) and
CD25CD4þCD45RAþ T cells with and without a stimulat-
ing antibody. We found that in the presence but not in the
absence of aCD3 stimulation several cytokines were secreted
at diverse levels upon coculture with plastic-adherent cells.
Not only proinflammatory cytokines (IL-1a, IL-1b, IL-2, IL-6,
IL-8, IFN-g, and tumor necrosis factor-a) but also anti-
inflammatory cytokines (IL-10, IL-13, and TGF-b) and other
cytokines were upregulated upon T-cell stimulation with an
aCD3 Ab (Supplementary Figure S3 online). Cocultures of
CD25CD4þCD45RAþ T cells and dermal cells contained
considerably more IL-1a and IL-1b compared with cocultures
with BM cells, whereas IL-17A was predominantly produced
upon coculture with BM cells and was almost absent upon
coculture with dermal cells. Huge and comparable amounts of
IL-6 were produced with dermal cells and BM cells but not
with HEK cells (Supplementary Figure S3 online). Cytokines
such as IL-4, IL-5, IL-7, IL-9, IL-15, IL-23, IL-25, and IL-33
were not detectable (data not shown).
CD90þ dermal cells vigorously induce FoxP3 expression in
CD25CD4þCD45RAþ T cells
Recently, we reported that plastic-adherent human dermal
cells comprise subsets of phenotypically defined MSC-alike
cells that possess distinctive differentiation capacities (Vaculik
et al., 2012). To assess whether this correlates with a diverse
FoxP3 induction potential, we compared plastic-adherent
dermal and BM cells with enriched dermal cells expressing
CD90, CD271, or CD73. Flow cytometric analysis revealed
that only a minute population of total dermal cells and a
negligible population of CD90þ dermal cells expressed
CD271 (Supplementary Figure S4a online). Interestingly, only
about 50% of dermal cells enriched for CD271þ expressed
CD90, whereas all CD271 cells uniformly expressed CD90.
Other MSC markers such as CD73 or CD26 were not
remarkably different (Supplementary Figure S4a and b online).
When comparing the different dermal subsets for their
FoxP3-inducing capacity, we found that CD90þ dermal cells
induced approximately 20% FoxP3 expression in aCD3-
stimulated CD25CD4þCD45RAþ T cells. Total dermal
cells or CD90 dermal cells induced 18.5% and 10%
FoxP3þ T cells, respectively (Figures 1d and 3a). CD271
dermal cells induced a higher percentage of FoxP3 compared
with cells positive for this marker (Figure 3a). The histogram
overlays show that different percentages of FoxP3þ T cells did
not result from increased or decreased T-cell proliferation
upon coculture, as CD4þ T cells always revealed the same
division cycle numbers (Figure 3a, histogram overlays: with
dermal cells, black line; without dermal cells, gray filled).
Statistical analysis of multiple experiments from different skin
donors showed a higher potential of plastic-adherent dermal
cells to induce FoxP3þ T cells upon TCR-complex stimulation
without CD28 costimulation compared with plastic-adherent
BM cells (Figure 3b). CD90þ dermal cells significantly induced
more FoxP3 than CD90 cells, whereas CD271 dermal cells
showed a tendency to induce more FoxP3 compared with
cells positive for this marker. In contrast, CD271þ cells have a
higher differentiation capacity compared with CD90þ cells or
total dermal cells (Vaculik et al., 2012). Both CD73þ and
CD73 dermal cells induced FoxP3 to a similar extent and
were largely comparable to that of total dermal cells (data not
shown). Thus, CD90þ dermal cells resemble a fibroblastoid
cell type, displaying minor MSC differentiation capacities
but robust immunomodulatory features via the induction of
suppressive Tregs.
CD90þ dermal cells localize predominantly perivascular
As shown above, CD90þ dermal cells are able to drive the
differentiation of CD25CD4þCD45RAþ T cells into func-
tional Tregs. CD90 is the counter-receptor for CD11b/CD18
(Wetzel et al., 2004) and may be an important molecule for
T-cell recruitment and homing to sites of inflammation. To
identify and localize CD90þ cells in situ, immunofluo-
rescence staining of skin cryostat sections was performed. In
noninflamed human skin, we found that CD90þ cells were
primarily distributed perivascularly, as shown by the CD90/
CD34 staining pattern (Figure 4a, arrows). Our further obser-
vation that CD3þ T cells are in close proximity to CD90þ
cells confirms and extends previous observations, showing the
preferential location of CD3þ T cells around postcapillary
venules of the superficial plexus (Nestle et al., 2009), thus
facilitating a local interaction (Figure 4b, arrows). In contrast,
some CD271þ cells coexpressed Col-IV, which is present in
the basement membranes of blood vessels, lymphatics, and
the peripheral nervous system but is never colocalized with
CD34þ blood vessels (Supplementary Figure S5a and b
online).
Dermal cells readily differentiate into endothelial cells
The close vicinity of CD90þ dermal cells to endothelial cells
of postcapillary venules not only positions these cells at the
site of T-cell infiltrates in inflamed tissue but also proposes a
role for CD90þ cells as a cell pool for tissue regeneration,
especially for blood vessel endothelial cells. To test this hypo-
thesis, we cultured plastic-adherent dermal cells (490%
express CD90) and CD271-enriched dermal cells (480%
expressed CD271) in proliferation medium as well as an
endothelial cell differentiation medium and quantified the
expression of endothelial cell surface markers using flow
cytometry. Dermal cells kept in differentiation medium not
only significantly increased the expression of the endothelial
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(progenitor) cell markers CD133, kinase insert domain recep-
tor, and CD34 but also highly upregulated proteins known to
be expressed on mature endothelial cells like CD31 and
CD144 (Figure 4c–g), whereas CD117 significantly decreased
after 17 days (Figure 4h). Surprisingly, CD271þ cells did not
differentiate toward the endothelial lineage (data not shown).
As CD90 acts as an activation-associated cell adhesion mole-
cule for leukocytes on dermal microvascular endothelial cells
(Wetzel et al., 2004), our data imply that perivascular CD90þ
dermal cells, which initially lack endothelial cell surface
markers, have the potential to replace damaged or degene-
rated endothelial cells to maintain the vascular integrity.
DISCUSSION
Using a carboxyfluoresceine succinimidyl ester-based division
tracing coculture system, we verified in this study that plastic-
adherent dermal cells suppressed T-cell proliferation stimu-
lated via aCD3/CD28 beads at high cell densities (Nauta and
Fibbe 2007). The suppression by dermal cells was cell-density
dependent (Le Blanc et al., 2003; Najar et al., 2009) and com-
parable to BM-MSCs (Ramasamy et al., 2008). Interestingly, low
numbers of dermal cells and BM-MSCs (ratio¼ 1:50) showed
no inhibitory but rather a stimulating capacity on T-cell
proliferation (data not shown), which has been reported
previously for BM cells (Le Blanc et al., 2003; Bocelli-Tyndall
et al., 2009; Najar et al., 2009). We found that dermal cells
were able to expand natural Tregs and increase the percentage
of activation-induced Tregs (d’Hennezel et al., 2011), suggest-
ing that dermal cells, like MSCs from BM and other tissues,
recruit, regulate, and expand existing suppressive natural Tregs
(Prevosto et al., 2007; Di Ianni et al., 2008). Dermal cells may
thus have an important role in the expansion and maintenance
of FoxP3þ Tregs in inflammatory conditions, where CD28
ligands (CD80, CD86) are upregulated.
Previous studies investigating the immunomodulatory role
of dermal MSCs always assumed the complete activation of T
cells via TCR/CD3 complex crosslinking and costimulation via
CD28. As experiments in the absence of CD28 co-ligation
might give insight into regulatory mechanisms to maintain
immune homeostasis, we introduced a CD28-independent
coculture system to mimic noninflammatory conditions
in human skin. Indeed, FoxP3 expression was significantly
induced in aCD3-stimulated FoxP3CD25CD4þCD45RAþ
T cells upon coculture with dermal cells after several division
cycles, which also mirrors the high plasticity between helper
T-cell subsets (O’Shea and Paul 2010). Our findings were
endorsed recently by Miskov-Zivanov et al. (2013) showing
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Figure 3. Differential forkhead box P3 (FoxP3)-inducing capacity of dermal
subsets. CFSE-stained CD25CD4þCD45RAþ T cells (5 104 cells per well)
were cultured in aCD3-coated (1mgml–1) 96-well plates with the indicated cell
types for 5 days (ratio 1:50). (a) Dot blots and histogram overlays (black
line¼with dermal cells; gray filled¼without) of cocultures with CD90þ and
CD90 as well CD271þ and CD271 dermal cells and subsequent staining
with an aFoxP3 mAb are demonstrated (representative experiment out of 3).
(b) Statistical evaluation of individual experiments with different skin and T-cell
donors revealed the highest potency of CD90þ dermal cells to induce FoxP3
in initially naive CD25CD4þCD45RAþ T cells without provision of
costimulatory molecules compared with all indicated cell types. The
Mann–Whitney U-test, *Po0.05, ***Po0.001. CFSE, carboxyfluoresceine
succinimidyl ester.
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that different helper T-cell subsets can be generated simulta-
neously depending on the mode and time of stimulation. It is
appealing that already minute numbers of plastic-adherent
dermal cells induce FoxP3 in aCD3-stimulated FoxP3
CD25CD4þCD45RAþ T cells and seem to reach a state
of saturation at low cell numbers. As it is known that strong
CD28 costimulation inhibits Treg induction rather than further
increasing the effect (Semple et al., 2011), it is conceivable
that a similar mechanism may be operative in our
experimental setup by yet to be defined costimulatory
pathways and has to be further explored. Dermal cell–
induced Tregs expressed low CD127 levels and were able to
suppress third-party T-cell proliferation, classifying them as
induced Tregs (Liu et al., 2006). It has been proposed that
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signals induced through CD28 ligation are vital for the survival,
homeostasis, and maintenance of Tregs in the periphery in
mice and men (Golovina et al., 2008; Guo et al., 2008). As
neither CD80 nor CD86 is upregulated on dermal cells, we
propose a CD28-independent induction and maintenance of
suppressive Tregs within healthy human skin. This suggests
that in vivo self-peptides are presented via HLA-DR, which
in combination with dermal cells potentially leads to the
induction of tissue-specific, peripheral induced Tregs. In line
with our hypothesis are data obtained in mice quite recently
(Azukizawa et al., 2011; Thompson et al., 2011). Together our
data imply that certain dermal cell subsets have a major role
in the regulation of T-cell activation under noninflammatory,
physiological conditions via the induction of suppressive
T cells.
The immunomodulatory function of dermal cells is based
on a cellular cross talk as investigations about the involvement
of constitutively secreted soluble factors revealed that condi-
tioned media from cultured dermal cells neither enhanced
T-cell proliferation nor induced FoxP3 expression (KP, unpub-
lished results). TGF-b can even substitute CD28 signaling in
Treg generation (Chen et al., 2003). TGF-b is expressed in the
epidermis but is virtually absent in healthy human dermis
in situ (Gruschwitz and Hornstein 1992; Schuster et al., 2009).
Interestingly, CD90þ fibroblasts, isolated from cancerous
tissue, produce significantly more TGF-b compared with
fibroblasts negative for this marker (Zhao and Peehl 2009).
Although we excluded the constitutive expression of TGF-b in
human dermis in situ, isolated dermal and BM cells produced
and secreted high amounts of TGF-b1, which is also present in
inflamed skin (Gruschwitz et al., 1990). Constitutive LAP
expression might be the key to ensure a rapid response to
environmental stimuli via cleavage of LAP and release of
active TGF-b. As we observed a reduction, but not the
complete abrogation of FoxP3 expression in our coculture
system using an aTGF-b-blocking Ab, we conclude that either
LAP is not cleaved sufficiently in our in vitro system or
multiple factors cooperate to induce FoxP3 expression, like
it has been reported for IL-2 in combination with TGF-b
(Davidson et al., 2007). However, the involvement of other
soluble factors like HLA-G5 and indoleamine 2,3-dioxygenase
in the dermal cell–driven generation of FoxP3þ Tregs can be
excluded, although the addition of indomethacin could fully
restore T-cell proliferation. In BM-MSCs, IL-6 can induce the
secretion of the potent immunosuppressive factor prostaglan-
din E2, which is also capable of inducing FoxP3 expression
(English et al., 2009). Prostaglandin E2 can be inhibited via
indomethacin (Bouffi et al., 2010). In line with this is our
observation that dermal as well as BM cells induced high
amounts of IL-6 beneath a plethora of other cytokines.
It was believed for a long time that the lack of cytokine
expression is a characteristic feature of Tregs (Yagi et al., 2004;
Baecher-Allan et al., 2006). Meanwhile, several studies
reported that diverse Treg subsets produce pro- and anti-
inflammatory cytokines, while maintaining FoxP3 expression
and their suppressive capacity (Duhen et al., 2012; Pesenacker
et al., 2013). Depending on culture conditions, the production
of Th1- and Th17-specific cytokines can be induced in
isolated and/or in vitro expanded Tregs (Beriou et al., 2009;
McClymont et al., 2011; McMurchy et al., 2013). Recently, IL-
10þ IFN-gþCD4þ regulatory T type 1–like cells were found
to be induced via MSC-secreted prostaglandin E2 in an
inflammatory disease model (Hsu et al., 2013). Further, it
has been proposed that MSCs are not constitutively immuno-
suppressive but rather acquire this function in response to
pro-inflammatory cytokines such as IFN-g or tumor necrosis
factor-a in combination with IL-1b (Su et al., 2013). Our
experiments revealed that the coculture of highly purified
CD25CD4þCD45RAþ T cells with plastic-adherent dermal
cells not only induced conventional FoxP3þ Tregs but also
generated a regulatory environment containing pro- and anti-
inflammatory cytokines. Interestingly, several cytokines (IL-2,
IL-10, IL-13, IL-27, IFN-g, tumor necrosis factor-a, and tumor
necrosis factor-b) were not secreted explicitly upon coculture
with dermal cells and aCD3 stimulation but also in cocultures
with BM cells and HEK cells. Although we did not identify
the exact mechanism responsible for dermal cell–induced
FoxP3 expression, our data suggest that more than one
mechanism is responsible for the immunosuppressive phe-
nomenon observed.
Similar to observations with CD90þ BM-MSCs (Campioni
et al., 2009), we found that CD90þ dermal cells induced
significantly higher percentages of FoxP3þ T cells compared
with CD90 cells, implying that a stem cell character is not
obligatory for the immunosuppressive activity, as we reported
previously that CD90þ dermal cells have a low mesenchymal
differentiation potential (Vaculik et al., 2012). The high
abundance of CD90þ cells (90% of total dermal cells)
(Vaculik et al., 2012) suggests the spatial regulation of these
cells within the skin. In situ localization of CD90þ dermal
cells revealed their predominant perivascular location. In
addition, single-cell immunofluorescence analysis showed
that few adherent dermal cells also expressed alpha-smooth
muscle actin, an actin isoform typical for smooth muscle cells
in vascular walls and pericytes surrounding endothelial cell
layers (Skalli et al., 1989). These findings are in accordance
with data reported for immunoregulatory stromal cells in the
BM as well as in the periphery (Shi and Gronthos 2003; da
Silva et al., 2008; Mendez-Ferrer et al., 2010; Le Blanc and
Mougiakakos 2012). The close vicinity to endothelial cells
might facilitate interactions with circulating lymphocytes with
an enhanced probability of immunomodulatory activities. The
concept of a microvascular unit in the human dermis, which
may contain perivascular macrophages, microvascular
endothelial cells, perivascular T cells, and mast cells, was
first postulated by Sontheimer (1989). In addition to the
scenario described above, and although memory (495%)
and not naive T cells are the dominant T-cell population in
adult human skin, one could think of a possible interaction of
skin-resident naive T cells residing in the microvascular unit
with CD90þ dermal cells sharing the same niche (Clark
2010). Further, CD90 expression allows the interaction with
endothelial cells (Wetzel et al., 2004). The potential of mouse
and swine BM-MSCs to differentiate toward the endothelial
lineage has been reported (Conrad et al., 2009; Pankajakshan
et al., 2013), but the close association of CD90þ dermal cells
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to the skin vasculature and their potential to similarly
differentiate toward the endothelial lineage has never been
shown previously to our knowledge. Possibly, CD90þ dermal
cells represent an important pool of progenitor cells for in situ
vessel regeneration and repair.
In summary, we provide evidence that CD90þ dermal cells
are important players in the CD28-independent generation of
de novo suppressive FoxP3þ Tregs. This could allow the
usage of dermal cells in the clinic for the maintenance of skin
immune homeostasis, possibly by inducing tolerance under
noninflammatory conditions. The close association of CD90þ
cells with the skin vasculature suggests their homing in a
perivascular niche, which allows the direct interaction with
lymphocytes. Moreover, plastic-adherent dermal cells are able
to differentiate toward the endothelial lineage, which suggests
that CD90þ cells build a local pool of vessel precursors. In
conclusion, dermal cells and specialized subsets may be
responsible for locally maintaining the tissue integrity and
the skin immune homeostasis.
MATERIALS AND METHODS
Cell isolation and culture
Dermal cells were isolated from noninflamed juvenile human
foreskin undergoing routine circumcision. The study was approved
by the ethics committee of the Medical University of Vienna
in accordance with the Declaration of Helsinki Principles, and
parents gave their written informed consent. Dermal and BM cells,
as well as peripheral blood mononuclear cells, were prepared and
cultured as described (Schuster et al., 2009; Vaculik et al., 2012).
HEK 293 cells were cultured in DMEM (Gibco, Carlsbad, CA), 10%
fetal calf serum (PromoCell, Heidelberg, Germany), and 1%
penicillin/streptomycin (Gibco). For certain experiments, dermal
and BM cells were cultured in eight-well chamber slides (2–
3 104 cells cm–2; Lab Tek, Nunc, Roskilde, Denmark), fixed with
MetOH Abs, and further processed for immunofluorescence.
Magnetic-activated cell sorting
Dermal sub-populations were enriched for CD90þ and CD271þ
sub-populations with the respective Abs using a magnetic-activated
cell sorting system (Miltenyi Biotech, Bergisch-Gladbach, Germany)
(Vaculik et al., 2012). The purity of the enriched cells ranged between
80 and 98% throughout all experiments.
CD3þCD4þCD45RAþCD25 and CD3þCD25 T cells were
isolated by initial depletion of CD25þ cells from total peripheral
blood mononuclear cells with an aCD25-APC mAb (clone 4E3;
Miltenyi Biotech) and anti-APC microbeads, followed by the use
of commercially available isolation kits for untouched, naive CD4þ
T cells and pan T cells (Miltenyi Biotech). For some experiments, pan
T cells were directly isolated from peripheral blood mononuclear
cells without prior depletion of CD25þ cells. The purity (498%) of
the cell fractions was determined using flow cytometry.
Coculture assays
Dermal, BM, and HEK 293 cells were irradiated (1 30 Gray,
Irradiator IBL 437C, CIS Bio International, Gif sur Yvette, France)
and cocultured with total or CD4þCD45RAþCD25 T cells (5 104
cells per well) and stained with carboxyfluoresceine succinimidyl
ester (0.5mM; Molecular Probes, Eugene, OR) at 37 1C for 10minutes
with or without soluble aCD28 mAbs (1mgml–1, BD Biosciences,
San Jose, CA). In some experiments, aCD3/CD28- and aCD3-coated
beads (Dynabeads, Invitrogen, Carlsbad, CA) were used for stimula-
tion of T cells (bead:cell ratio¼ 1:1) in cocultures with dermal and
BM cells. Proliferation/inhibition was analyzed either by flow cyto-
metry (LSR II, BD, Franklin Lakes, NJ) or by [3H]-TdR incorporation
(Schuster et al., 2009). Kinetic experiments revealed that the prolifera-
tion profile of aCD3/CD28-stimulated T cells remained virtually
constant during the observation period of 3–6 days using [3H]-TdR
incorporation assays. On the basis of these results, we have chosen
day 4 for the proliferation assessment. For the analysis of Treg cell–
induced T-cell suppression, T cells from cocultures with dermal cells
or T cells alone (with/without stimulation) were pooled, irradiated,
and cocultured with CD25CD3þ cells and stimulated with aCD3/
CD28-coated beads for 4 days. T cells were pulsed for the final
18hours with [3H]-TdR and analyzed. In certain blocking experi-
ments, selected concentrations of blocking mAbs (aTGF-b (R&D
Systems, Minneapolis, MN), aHLA-G5, isotype controls), indometha-
cin (Sigma, St Louis, MO), or solvent (MetOH) were added to the
cocultures before the evaluation of FoxP3 expression or T-cell
proliferation.
Cytokine determination
Cell-free cell culture supernatants (100ml per well) of dermal, BM,
and HEK cells either cultured alone or with CD4þCD45RAþCD25
T cells (adherent cell:T-cell ratio¼ 1:50) without and with aCD3
stimulation (1mgml–1 plate-bound UCHT-1 mAb) were analyzed after
5 days for cytokines by means of Luminex xMAP suspension array
technology (Luminex, Austin, TX). Standard curves were generated
using recombinant cytokines (R&D Systems). Experiments were
performed with each sample in duplicate, and data are expressed
as mean values±SD.
Flow cytometry
Single-cell suspensions were stained with the following mAbs: phy-
coerythrin aCD4 (clone M-T466; Miltenyi Biotech), FITC aCD45RA
(clone T6D11; Miltenyi Biotech), APC aCD3 (clone SK7; BD),
CD127, FITC aCD80 (clone L307.4; BD), FITC aCD86 (clone FUN-1;
BD), APC CD25 (clone 4E3; Miltenyi Biotech), APC aCD133/2
(Miltenyi Biotech), APC ac-KIT (BD Biosciences), APC aCD34
(Immunotools, Friesoythe, Germany), APC aCD31 (Immunotools),
FITC aVE-cadherin (Bender MedSystems, eBioscience, San Diego, CA),
and APC a-kinase insert domain receptor (Miltenyi Biotech). Appro-
priate isotype controls were included. Dead cells were excluded
with 7-aminoactinomycin (Sigma). Cells were examined on a LSRII
(running FACS Diva, BD) or FACSCalibur (BD), and data were
analyzed with FlowJo software (Version 7.2.5, Tree Star, Ashland,
OR) or CellQuest software (BD). For intracellular/intranuclear stain-
ing, cells were fixed with 4% formaldehyde, permeabilized with 0.1%
saponin (Sigma), and stained with an AF647 aFoxP3 mAb (BD) or the
isotype control (BD).
Immunofluorescence and immunohistochemistry
Skin cryosections or single cells fixed on chamber slides were stained
with phycoerythrin aCD90 (clone 5E10; BD), phycoerythrin aCD73
(clone AD2; BD), FITC aCD105 (clone 166707; R&D Systems), FITC
aalpha-smooth muscle actin (clone 1A4; Sigma), phycoerythrin
aCD271 (clone C40-1457; BD), FITC aCD31 (clone WM59; Serotec,
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Oxford, UK), APC aCD3 (clone SK7; BD), and aLAP (clone 27232; R&D
Systems) in combination with secondary AF488 aIgG, washed, and
mounted with mounting medium containing DAPI (Vectashield,
Vector Laboratories, Burlingame, CA). Isotype-matched controls were
included. Pictures were captured with a confocal laser scanning micro-
scope (CLSM 510, Zeiss, Jena, Germany) or a compound microscope
(Eclipse 80, Nikon, Tokyo, Japan). Arbitrary units were calculated using
free ImageJ software (http://imagej.nih.gov/ij/docs/index.html). TGF-
staining was performed as reported (Schuster et al., 2009).
Induction of endothelial cell differentiation
Plastic-adherent dermal cells were analyzed for markers expressed on
endothelial cells (CD31 (o0.5%), CD34 (o0.7%), CD144 (o0.1%)),
endothelial progenitors (CD133 (o0.3%)), and hematopoietic cells
(CD45 (o0.1%)). Subsequently, the cells were subjected to endothe-
lial cell differentiation assays. They were seeded in 12-well plates
(8 104 per well) and cultured with human endothelial– serum-free
medium growth medium (Invitrogen) supplemented with 2mM
glutamine, monothioglycerol (Sigma-Aldrich, St Louis, MO), endothe-
lial cell growth supplement (Technoclone, Vienna, Austria), heparin
(Calbiochem/Merck, Darmstadt, Germany), human basic fibroblast
growth factor, human bone morphogenic protein 4, human IL-6,
human epidermal growth factor, human vascular endothelial growth
factor, and human erythropoietin (all from R&D Systems). Briefly, on
day 0 cells were seeded in 8 wells of a 12-well plate (4 wells with
proliferation medium and 4 wells with differentiation medium). Three
wells were harvested and assessed by flow cytometric analysis on
days 7 and 14, and the fourth well was reseeded in four wells. After
analysis on day 17, cells were reseeded in three wells only for final
analysis on day 21. In addition, the medium was exchanged on days
3 and 10 of cultivation.
Statistical analysis
Data analysis was performed using GraphPad Prism5 (GraphPad
Software, La Jolla, CA). Data were analyzed by the Mann–Whitney
test or the Student’s t-test, and Po0.05 was considered significant.
Data are expressed as mean % expression (± SEM or SD).
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